| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.7M | +25.7% |
| Cost of Revenue | $3.2M | -10.9% |
| Gross Profit | $5.5M | +66.1% |
| R&D Expense | $3.4M | -53.3% |
| SG&A Expense | $6.9M | -26.5% |
| Operating Income | -$1.7M | +91.0% |
| Interest Expense | $121K | -84.4% |
| Net Income | -$2.8M | +78.9% |
| EPS (Basic) | -$0.94 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $859K | -48.7% |
| Current Assets | $2.8M | -20.5% |
| Total Assets | $6.3M | -35.8% |
| Current Liabilities | $5.0M | -33.9% |
| Total Liabilities | $5.0M | -34.3% |
| Stockholders' Equity | $496K | -83.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.8M | +78.0% |
| Capital Expenditures | $25K | -21.0% |
| Investing Cash Flow | $1.2M | -71.9% |
| Financing Cash Flow | $834K | -91.6% |
| Free Cash Flow | -$2.9M | +77.9% |
| -118.6% |
| EPS (Diluted) | -$0.94 | -118.6% |